Clinical Trial Update: PsilOCD: A Pharmacological-Challenge Feasibility Study [Phase 1]

View source ↗

Summary

Phase 1 feasibility study for Obsessive-Compulsive Disorder (PsilOCD) conducted by Imperial College London has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Snippet

Sponsor: Imperial College London | Conditions: Obsessive-Compulsive Disorder | Phase 1 | Status: COMPLETED